The clinician and the thyroid

Biersack, H.-J.; Hotze, A.

doi:10.1007/bf00173437

Cited by 6 publications

(7 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Er concentration profiles in WO 3 films were simulated using the dynamic TRIM (transport of ions in matter [14]) code "T-DYN 4.0" [15]. Figs.1a-e show the Er depth profiles for different fluences.…”

Section: Film Composition and Structurementioning

confidence: 99%

Physical properties of erbium implanted tungsten oxide films deposited by reactive dual magnetron sputtering

Mohamed

Anders

2007

Thin Solid Films

View full text Add to dashboard Cite

Amorphous and partially crystalline WO 3 thin films were prepared by reactive dual magnetron sputtering and successively implanted by erbium ions with a fluence in the range from 7.7 × 10 14 to 5 × 10 15 ions/cm 2 . The electrical and optical properties were studied as a function of the film deposition parameters and the ion fluence. Ion implantation caused a strong decrease of the resistivity, a moderate decrease of the index of refraction and a moderate increase of the extinction coefficient in the visible and near infrared, while the optical band gap remained almost unchanged. These effects could be largely ascribed to ion-induced oxygen deficiency. When annealed in air, the already low resistivities of the implanted samples decreased further up to 70ºC, whereas oxidation, and hence a strong increase of the resistivity, was observed at higher annealing temperatures.

show abstract

Section: Film Composition and Structurementioning

confidence: 99%

Physical properties of erbium implanted tungsten oxide films deposited by reactive dual magnetron sputtering

Mohamed

Anders

2007

Thin Solid Films

View full text Add to dashboard Cite

show abstract

“…Either thyroid hormone or TSH level estimations serve as basic tests in suspected thyroid dysfunction. They are also used in determining the severity of thyroid hyper-and hypofunction and in monitoring known thyroid dysfunction, especially under thyrosuppressive or depressive therapy 8 .…”

Section: Introductionmentioning

confidence: 99%

İron Metabolism i̇n Pati̇ents With Impaired Thyroid Function : Ti̇roi̇d Fonksi̇yon Bozukluğu Olan Hastalarda Demi̇r Metaboli̇zmasi

Onat¹,

Gönenç²,

Gürcan³

et al. 2003

Ankara Universitesi Eczacilik Fakultesi Dergisi

View full text Add to dashboard Cite

show abstract

“…Morita [5] and Biersack [26] reported a positive correlation between volume reduction and Tg suppression in their patients. No uniform correlation was found between volume changes and thyroglobulin levels in the present study as with Feldt-Rasmussen [11] and Papini [18] who also failed to observe such a correlation.…”

Section: Discussionmentioning

confidence: 90%

Suppressive Therapy with Levothyroxine for Euthyroid Diffuse and Nodular Goiter.

et al. 1999

View full text Add to dashboard Cite

In this study, 35 patients with euthyroid diffuse goiter and 35 patients with euthyroid nodular goiter were treated with Levothyroxine (L-T4) for six months. The aim was to evaluate the efficacy of treatment on thyroid and nodule volumes and to evaluate the correlation between volume changes and thyroglobulin levels. Serum thyroid hormones, TSH, thyroglobulin, thyroid and nodule volumes were measured at the initial visit and after 6 months. Radioactive iodine uptakes of the thyroid gland were evaluated before treatment. The mean decrease of thyroid volume at six months was about 20% (20.4 +/- 8.8 ml vs. 16 +/- 7.9 ml, P<0.001) in patients with diffuse goiter. All patients with diffuse goiter showed some decrement in their goiter sizes. Thyroid nodules, in response to thyroid hormone treatment, showed a variable behavior. A reduction of 50% or more in volume was detected in 31% (11/35) of the patients. 54% of the patients (19/35) showed a 10-49% decrease in nodule volume. Five of the patients were found to be insensitive to the therapy. Their nodule volumes either increased or did not change during therapy. Free T4 and free T3 levels increased and TSH levels decreased with L-T4 treatment in all patient groups. Patients with higher TSH levels (within normal limits) showed more volume reduction in the diffuse goiter group. No uniform correlation was found between volume changes and thyroglobulin levels in either of the patient groups. In conclusion, suppressive thyroxine treatment is effective in reducing the size of the goiter, and nodules and thyroglobulin levels cannot be taken as an indicator of the efficacy of L-T4 therapy.

show abstract

The clinician and the thyroid

Cited by 6 publications

References 21 publications

Physical properties of erbium implanted tungsten oxide films deposited by reactive dual magnetron sputtering

Physical properties of erbium implanted tungsten oxide films deposited by reactive dual magnetron sputtering

İron Metabolism i̇n Pati̇ents With Impaired Thyroid Function : Ti̇roi̇d Fonksi̇yon Bozukluğu Olan Hastalarda Demi̇r Metaboli̇zmasi

Suppressive Therapy with Levothyroxine for Euthyroid Diffuse and Nodular Goiter.

Contact Info

Product

Resources

About